The antiproliferative and apoptotic effects of apigenin on glioblastoma cells.
Trevor A StumpBrittany N SanteeLauren P WilliamsRachel A KunzeChelsae E HeinzeEric D HusemanRebecca J GrykaDenise S SimpsonSamson AmosPublished in: The Journal of pharmacy and pharmacology (2017)
Our results demonstrated that apigenin has potent inhibitory effects on pathways involved in GBM proliferation and survival and could potentially be used as a therapeutic agent for GBM.